SY-4835
/ Shouyao Holdings
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 16, 2024
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Shouyao Holdings (Beijing) Co. LTD | Trial completion date: Dec 2023 ➔ Dec 2024 | Trial primary completion date: Nov 2023 ➔ Jun 2024
Metastases • Trial completion date • Trial primary completion date • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
April 12, 2023
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Shouyao Holdings (Beijing) Co. LTD | Trial completion date: Jul 2023 ➔ Dec 2023 | Trial primary completion date: Jun 2023 ➔ Nov 2023
Metastases • Trial completion date • Trial primary completion date • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
March 22, 2022
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Shouyao Holdings (Beijing) Co. LTD
New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1